Перейти к анализу отчёта
← Назад к ленте
MOS FY2025 Q4 SOFTENING

Отчётный звонок Mosaic Company (The)

Feb 25, 2026 · 11:00 ET Bruce BodineJason TremblayJenny Wong
Вывод Buzzberg

2026 CapEx expected to be ~$1.5B, higher than 2025

Mosaic reported a Q4 that was weaker than expected due to a sharp fall in US phosphate demand. Management guided to a difficult first half of 2026 due to high sulfur costs, but expects a demand recovery and working capital release to drive progressively improving cash flow. Management expects roughly a $250 million EBITDA headwind in Q1-26 due to high sulfur costs, which will compress phosphate margins.

Вывод Buzzberg 2026 CapEx expected to be ~$1.5B, higher than 2025 Mosaic reported a Q4 that was weaker than expected due to a sharp fall in US phosphate demand. Management guided to a difficult first half of 2026 due to high sulfur costs, but expects a demand recovery and working capital release to drive progressively improving cash flow. Management expects roughly a $250 million EBITDA headwind in Q1-26 due to high sulfur costs, which will compress phosphate margins. Читать полный анализСвернуть анализ

Mosaic reported a Q4 that was weaker than expected due to a sharp fall in US phosphate demand. Management guided to a difficult first half of 2026 due to high sulfur costs, but expects a demand recovery and working capital release to drive progressively improving cash flow. Management expects roughly a $250 million EBITDA headwind in Q1-26 due to high sulfur costs, which will compress phosphate margins.

  • Mosaic idled its lowest-margin operations in Brazil (Araxá and Fospar) indefinitely in response to the sulfur cost spike.
  • The company is guiding to 2026 capex of ~$1.5 billion, higher than 2025, due to lumpy environmental projects.
  • Despite cost headwinds, Mosaic expects a $300-500 million working capital release in 2026 from inventory unwind, particularly in phosphates.
Revenue $2.6034B reported
EPS $0.22 reported
Gross margin 14.17% reported
Op margin 9.05% reported

Что изменилось в этом квартале

01
Capex

2026 CapEx expected to be ~$1.5B, higher than 2025

Management expects 2026 CapEx to be around $1.5 billion, higher than 2025, due to gyp stack, clay settling area, and tailings dam expansions in Florida and Brazil. They expect CapEx to trend down to approximately $1 billion by 2030, with ARO and environmental reserve spending…

02
Margins

Sulfur price spike expected to compress phosphate margins into H1 2026

Reported gross margin was 14.17%, reinforcing the quarter's better-than-guided profitability.

03
Costs

Company targets another $100 million cost savings in 2026

Mosaic idled its lowest-margin operations in Brazil (Araxá and Fospar) indefinitely in response to the sulfur cost spike.

04
Growth

Mosaic Biosciences expected to double net sales again in 2026

The company is guiding to 2026 capex of ~$1.5 billion, higher than 2025, due to lumpy environmental projects.

Спрос и капзатраты

Спрос

Заказы и конверсия

Phosphate demand in US emerging as spring approaches. Management acknowledges a challenging 2025 and near-term headwinds from sulfur costs, but expresses confidence in improved production, cost savings, and strong long-term market fundamentals.

Капзатраты

Инвестиции и мощности

Management expects 2026 CapEx to be around $1.5 billion, higher than 2025, due to gyp stack, clay settling area, and tailings dam expansions in Florida and Brazil. They expect CapEx to trend down to approximately $1 billion by 2030, with ARO and environmental reserve spending declining to about $200 million.

Тон · Cautiously Optimisti

Management acknowledges a challenging 2025 and near-term headwinds from sulfur costs, but expresses confidence in improved production, cost savings, and strong long-term market fundamentals.

Альфа цепочки поставок

A1

Mosaic has idled its lowest-margin Brazilian operations (Araxá, Fospar) indefinitely due to the sharp spike in sulfur prices, indicating a significant supply response in the Brazilian phosphate market.

“We have idled Ayrshire and Fosbar in Brazil, our lowest margin operations until further notice.”
Bruce Bodine
A2

The spike in sulfur prices is expected to compress phosphate margins at least through the first half of 2026, with every $10 increase in sulfur adding ~$10 million to quarterly expense.

“Every $10 increase in sulfur prices adds approximately $10 million of quarterly expense. Compared with the prior year first quarter, we thus expect a roughly 250 million headwind to Q1-26 EBITDA.”
Luciano Ciani-Perez
A3

Mosaic exited Q4 2025 with ~240,000 tons of excess phosphate product inventory, representing ~$140 million of potential working capital release, which is expected to unwind through 2026 as demand recovers.

“We exited 2025 with about 240,000 tons of excess inventory in phosphates versus the prior year. At current inventory values, this represents roughly $140 million of potential working capital release over the next few quarters from demand r…”
Luciano Ciani-Perez
A4

Mosaic is experiencing a pronounced disconnect between U.S. and international phosphate prices; international DAP netback prices are now at a premium to NOLA, leading the company to shift sales volumes to international markets.

“In fact, today, International market price for DAP, net back is actually at a higher premium than the NOLA price”
Jenny Wong

Прогноз компании

SofteningGuidance tone
Прогноз компании
ПоказательПериодДиапазонСерединаСтатус
CapexFY2026$1.5B$1.5BGUIDED